Papers

1

Total Citations

1,480

H-Index

1

About

Yiguo Zou is a pioneering researcher in the field of DNA nanotechnology and targeted cancer therapy. His most impactful work, a 2018 study published in *Nature Biotechnology*, introduced a DNA nanorobot that functions as a cancer therapeutic in response to a molecular trigger in vivo. This landmark paper, with over 1,480 citations, demonstrated how programmable DNA origami structures can deliver payloads specifically to tumor sites, opening new avenues for precision medicine. Zou’s contributions lie at the intersection of synthetic biology and nanomedicine, where he has advanced the design of stimuli-responsive nanodevices that operate within living organisms. His research has been widely recognized for its potential to revolutionize drug delivery, reducing off-target effects while enhancing therapeutic efficacy. Beyond this flagship work, Zou continues to explore dynamic DNA systems for biomedical applications, earning him a reputation as a leader in the emerging field of DNA robotics. His achievements underscore a career dedicated to translating molecular engineering into tangible clinical solutions.

Research Focus

Key Achievements

1
H-Index
1
Papers
1,480
Total Citations
1,480
Avg Citations/Paper
🏆 Most Cited Paper
A DNA nanorobot functions as a cancer therapeutic in response to a molecular trigger in vivo
1,480 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 17
🏛 Institutions: National Center for Nanoscience and Technology

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago